Chemotherapy News and Research

Latest Chemotherapy News and Research

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

GTx, Inc. announced today there will be two scientific poster presentations on the effects of enobosarm, a selective androgen receptor modulator (SARM), on improving physical function and quality of life in middle aged and elderly cancer patients.

8 Oct 2012

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) doubles the response rate and improves time-to-progression and survival in patients with advanced lung cancer, according to a Phase II clinical trial conducted by investigators at Rational Therapeutics and the MemorialCare Todd Cancer Institute and published in the October issue of Anticancer Research.

8 Oct 2012

Patient navigation services can reduce dangerous delays in identification of breast cancer

Today researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation services.

8 Oct 2012

Researchers discover brain mechanism responsible for sensation of nausea

Nausea is a common and distressing side effect of many drugs and treatments. Unlike vomiting, nausea is not well understood, but new research by University of Guelph scientists may soon change that.

6 Oct 2012

GW professor to develop blood test for early detection of breast cancer

Today, patients with precancerous lesions, or early-stage breast cancer are usually diagnosed after a mammography screening. This method of detection can lead to false-positives and overtreatment, since mammography cannot determine whether pre-cancerous cells will actually turn into breast cancer. This may all change after Sidney Fu, M.D., professor of medicine at the George Washington School of Medicine and Health Sciences (SMHS), completes his study of early breast cancer detection using novel small RNA (microRNA or miRNA) biomarkers.

5 Oct 2012

New book on natural interventions for lung cancer

Told he had lung cancer and 6 months to live, the author refused chemo/surgery and used holistic, natural, non-invasive interventions. Now, 38 years later at age 80 he not only beat the odds of lung cancer but also the odds of 3 chronic illnesses and 5 prescribed medications that are the average for a 75 year old.

5 Oct 2012

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.

4 Oct 2012

New type of drug for drug-resistant cancer

New drug may be an effective alternative for patients whose cancer is resistant to currently available drugs.

4 Oct 2012

Roundup: Individual mandate back on Fla. ballot; More Mass. doctors embrace new payment methods; Ga. hospital tax fight rages on

In a bid to remake Florida's judiciary, Republicans are asking voters to oust three state Supreme Court justices and give the Legislature greater power over Supreme Court appointments. ... In Florida, the issue is not same-sex marriage but another politically divisive matter: President Obama's health care law. In a 2010 ruling, the Florida Supreme Court removed from the ballot a nonbinding amendment allowing Floridians to refuse to buy mandatory health insurance.

4 Oct 2012

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Bone marrow transplant (also called stem cell transplant) is a medical intervention that allows a physician to deliver very high doses of chemotherapy (if needed) but more importantly, deliver a new immune system to the patient to fight a disease (such as cancer).

3 Oct 2012

Senate leaders working on post-election plan to avoid 'fiscal cliff'

The New York Times reports that a bipartisan group is trying to find a path to a deficit reduction deal, but Democrats and Republicans still remain far apart on details.

3 Oct 2012

ASTRO selects Boston-area resident as 2012 Survivor Circle Award winner

The American Society for Radiation Oncology (ASTRO) has selected Boston-area resident and prostate cancer survivor Emanuel "Manny" Hamelburg as its 2012 Survivor Circle Award winner.

3 Oct 2012

CINJ database enhancements help physicians to ensure safety in chemotherapy delivery

Database enhancements developed at The Cancer Institute of New Jersey (CINJ) are helping physicians use technology to further ensure safety in the delivery of chemotherapy.

3 Oct 2012

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers--genetic characteristics that are associated with some patients with breast cancer--can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

3 Oct 2012

F-18-FLT-PET predicts early response to chemoradiotherapy in head and neck cancer

Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.

2 Oct 2012

Loyola launches experimental immune system therapy clinical trial for melanoma in the Midwest

Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer.

2 Oct 2012

GnRH agonist may protect breast cancer patient fertility

Treatment with a gonadotropin-releasing hormone agonist may reduce the risk for chemotherapy-induced amenorrhea, research shows.

1 Oct 2012

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

ProStrakan Group plc announces today that it has acquired exclusive US commercial rights to Fareston (toremifene citrate) for the treatment of metastatic breast cancer in postmenopausal women.

1 Oct 2012

Five prominent surgeons receive Honorary Fellowship from ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to five prominent surgeons from Japan, the Philippines, Mexico, England, and Belgium during Convocation ceremonies that preceded the official opening of the 2012 ACS Annual Clinical Congress.

1 Oct 2012

Takeda, Seattle Genetics announce preliminary data from brentuximab vedotin phase I study on sALCL

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Seattle Genetics, Inc., today announced preliminary data from one arm of a three arm phase I, open-label, multicenter study designed to determine the safety and activity of sequential and combination treatment approaches of brentuximab vedotin with CHOP or CH-P chemotherapy in newly diagnosed patients with CD30-positive mature T- and NK- cell lymphomas.

1 Oct 2012

Chemotherapy News and Research

Latest Chemotherapy News and Research

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Patient navigation services can reduce dangerous delays in identification of breast cancer

Researchers discover brain mechanism responsible for sensation of nausea

GW professor to develop blood test for early detection of breast cancer

New book on natural interventions for lung cancer

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

New type of drug for drug-resistant cancer

Roundup: Individual mandate back on Fla. ballot; More Mass. doctors embrace new payment methods; Ga. hospital tax fight rages on

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Senate leaders working on post-election plan to avoid 'fiscal cliff'

ASTRO selects Boston-area resident as 2012 Survivor Circle Award winner

CINJ database enhancements help physicians to ensure safety in chemotherapy delivery

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

F-18-FLT-PET predicts early response to chemoradiotherapy in head and neck cancer

Loyola launches experimental immune system therapy clinical trial for melanoma in the Midwest

GnRH agonist may protect breast cancer patient fertility

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

Five prominent surgeons receive Honorary Fellowship from ACS

Takeda, Seattle Genetics announce preliminary data from brentuximab vedotin phase I study on sALCL

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in